🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Walt Disney, Exxon, Lockheed Martin rise premarket; Spotify, Delta fall

Published 09/10/2023, 13:20
© Reuters
CVX
-
DIS
-
NOC
-
LMT
-
XOM
-
BMY
-
DAL
-
UAL
-
MRTX
-
AAL
-
SPOT
-

Investing.com -- U.S. futures slumped Monday, as investors fretted over the impact of the intensifying conflict between Israel and Hamas and looked ahead to fresh inflation data later this week.

Here are some of the biggest premarket U.S. stock movers today:

  • Walt Disney (NYSE:DIS) stock rose 1.3% after the WSJ reported that Nelson Peltz's Trian Fund Management has increased its stake in the entertainment giant and the activist investor is expected to request multiple board seats, including for himself.

  • Citigroup (NYSE:C) stock fell 0.9% after the banking giant agreed to sell its retail wealth management portfolio in mainland China to HSBC (NYSE:HSBC), down 2.4%.

  • United Airlines (NASDAQ:UAL) stock fell 2.8%, American Airlines (NASDAQ:AAL) stock fell 3% and Delta Air Lines (NYSE:DAL) stock dropped 3%, with several airlines having halted or reined in some flights to Israel following the escalation of violence between the country's forces and Palestinian group Hamas.

  • Spotify (NYSE:SPOT) stock fell 2.2% after Redburn-Atlantic downgraded its stance on the audio streaming service to ‘neutral’ from ‘buy’, estimating the company’s new audiobook offer will be gross margin dilutive.

  • Exxon Mobil (NYSE:XOM) stock rose 2.5% and Chevron (NYSE:CVX) stock rose 2.6% after oil prices surged as the escalated conflict in the Middle East raised concerns about future global supply.

  • Lockheed Martin (NYSE:LMT) stock rose 4.8%, Northrop Grumman (NYSE:NOC) stock rose 3.3% and RTX (NYSE:RTX) stock rose 3.6% as these defense stocks gain on the expectation of increased spending given the increased geopolitical tension.

  • Bristol-Myers Squibb (NYSE:BMY) stock fell 1.3% after the pharmaceutical company said it will acquire cancer drugmaker Mirati Therapeutics (NASDAQ:MRTX), down 5.2%, for up to $5.8 billion, diversifying its oncology business.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.